Preclinical and clinical research spans postoperative and cancer-related pain
SINGAPORE, October 21, 2026 — PVP Labs announced that four scientific abstracts on Taphalgin® (lumekefamide), the company’s…
A determination that a substance is not scheduled under the Controlled Substances Act tends to be read as a verdict on whether that substance is…
Provisional data from the CDC's National Center for Health Statistics put US drug overdose deaths at an estimated 69,973 in 2025, down almost 14% from…
KISSIMMEE, Fla., July 30, 2026 — Research on Taphalgin® (lumekefamide), PVP Labs’ lead investigational candidate, was selected for oral presentation at the 2026 Military Health System…
Why Biologics' Middle Child Is Driving Biotech Growth
For decades, the pharmaceutical industry operated on a binary paradigm: small molecules and large biologics. Small molecules…
How Regulatory Shifts Are Redefining Pain Management in 2026
The global pain management landscape is undergoing its most significant transformation in decades. For years, the…